Trial Profile
Optimizing Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Aug 2023
Price :
$35
*
At a glance
- Drugs Bupropion (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 14 Aug 2023 Status changed from recruiting to completed.
- 02 Nov 2021 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.
- 02 Nov 2021 Planned primary completion date changed from 31 Dec 2023 to 31 Dec 2024.